Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 1, 2001, Pages 55-65

  Sun, Z ^a   Wang, X ^a   Lasson, A ^a   Bojesson A ^a   Annborn, M ^a   Andersson, R ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adhesion molecules; Barrier; Cytokine; Endothelium; Epithelium; Leukocyte; Permeability; Prot ease inhibitors

Indexed keywords

CD31 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1BETA; LEXIPAFANT; MONOCLONAL ANTIBODY; MYELOPEROXIDASE; PROTEINASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENTEROPATHY; ENZYME ACTIVITY; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; LEUKOCYTE MIGRATION; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REPERFUSION;

EID: 0035133344     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520150218066     Document Type: Article

References (39)

1. Acute superior mesenteric ischemia
2. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion
3. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats
4. Hypoxia/reoxygenation of human endothelium activates PMNs to detach endothelial cells via a PAF mechanism
5. Inhibition of platelet-activating factor, intercellular adhesion molecular-1 and platelet endothelial cell adhesion molecule-1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction
6. Leukocyte-endothelial cell interactions: Molecular mechanisms and implications in gastrointestinal disease
7. Cytokine-induced increases in endothelial permeability occur after adhesion molecule expression
8. The role of endothelial cells in systemic inflammatory response syndrome and multisystem organ failure
9. The influence of circulatory and gut luminal challenges on bidirectional intestinal barrier permeability in rats
10. Neutrophil, accumulation in ischemic reperfused rat liver: Evidence for a role for superoxide free radicals
11. Electroimmunoassay
12. Chromogenic peptide substrate assays and their clinical applications
13. Mediators of multiple organ failure
14. Differential effects of IL-1β and ibuprofen after endotoxic challenge in mice
15. Adhesion molecules and inflammatory injury
16. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo
17. Cytokines released from reperfused human intestine upregulate ELAM-1
18. Involvement of neutrophils in ischemia-reperfusion injury in the small intestine
19. Gut origin sepsis, macrophage function, and oxygen extraction associated with acute pancreatitis in the rat
20. The role of intravenous administration of dextran 70 in enteric bacterial translocation after partial hepatectomy in rats
21. Proteolytic cleavage and inactivation of α-2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase
22. Ischemia-reperfusion mechanisms in acute pancreatitis
23. Fibrinolysis in relation to lungs and ARDS
24. Extracellular proteolysis in the adult murine brain
25. The interaction of alpha-2-macroglobulin with proteinases
26. Alpha-2-macroglobulin: A multifunctional and targeting protein with possible roles in immunity and autoimmunity
27. To stick or not to stick: The new leukocyte homing paradigm
28. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human intestinal microvascular endothelial cells
29. Role of cytokines and their inhibitors in acute pancreatitis
30. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1
31. Endothelial-leukocyte adhesion molecules
32. Adhesion molecules in inflammatory bowel disease
33. In situ expression of the cell adhesion molecules in inflammatory bowel disease: Evidence of immunologic activation of vascular endothelial cells
34. Role of cell adhesion molecules in inflammatory bowel diseases
35. The biology of PECAM-1
36. Cytokines et les infections bacteriennes et parasitaires
37. Interleukin-1 and its relationship to endotoxin tolerance
38. Transcriptional regulation of endothelial cell adhesion molecules: NF-kB and cytokine-inducible enhancers
39. The proteasome pathway is required for cytokine-induced endothelial leukocyte adhesion molecule expression